The role of retinoic acid in hepatic lipid homeostasis defined by genomic binding and transcriptome profiling
View/ Open
Issue Date
2013-08-28Author
He, Yuqi
Gong, Lei
Fang, Yaping
Zhan, Qi
Liu, Hui-Xin
Lu, Yanliu
Guo, Grace L.
Lehman-McKeeman, Lois
Fang, Jianwen
Wan, Yu-Jui Yvonne
Publisher
BioMed Central
Type
Article
Article Version
Scholarly/refereed, publisher version
Rights
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metadata
Show full item recordAbstract
Background:
The eyes and skin are obvious retinoid target organs. Vitamin A deficiency causes night blindness and retinoids are widely used to treat acne and psoriasis. However, more than 90% of total body retinol is stored in liver stellate cells. In addition, hepatocytes produce the largest amount of retinol binding protein and cellular retinoic acid binding protein to mobilize retinol from the hepatic storage pool and deliver retinol to its receptors, respectively. Furthermore, hepatocytes express the highest amount of retinoid x receptor alpha (RXRα) among all the cell types. Surprisingly, the function of endogenous retinoids in the liver has received very little attention.
Results:
Based on the data generated from chromatin immunoprecipitation followed by sequencing, the global DNA binding of transcription factors including retinoid x receptor α (RXRα) along with its partners i.e. retinoic acid receptor α (RARα), pregnane x receptor (PXR), liver x receptor (LXR), farnesoid x receptor (FXR), and peroxisome proliferator-activated receptor α (PPARα) has been established. Based on the binding, functional annotation illustrated the role of those receptors in regulating hepatic lipid homeostasis. To correlate the DNA binding data with gene expression data, the expression patterns of 576 genes that regulate lipid homeostasis were studied in wild type and liver RXRα-null mice treated with and without RA. The data showed that RA treatment and RXRα-deficiency had opposite effects in regulating lipid homeostasis. A subset of genes (114), which could clearly differentiate the effect of ligand treatment and receptor deficiency, were selected for further functional analysis. The expression data suggested that RA treatment could produce unsaturated fatty acids and induce triglyceride breakdown, bile acid secretion, lipolysis, and retinoids elimination. In contrast, RXRα deficiency might induce the synthesis of saturated fatty acids, triglyceride, cholesterol, bile acids, and retinoids. In addition, DNA binding data indicated extensive cross-talk among RARα, PXR, LXR, FXR, and PPARα in regulating those RA/RXRα-dependent gene expression levels. Moreover, RA reduced serum cholesterol, triglyceride, and bile acid levels in mice.
Conclusions:
We have characterized the role of hepatic RA for the first time. Hepatic RA mediated through RXRα and its partners regulates lipid homeostasis.
Collections
Citation
He, Yuqi, Lei Gong, Yaping Fang, Qi Zhan, Hui-Xin Liu, Yanliu Lu, Grace L Guo, Lois Lehman-McKeeman, Jianwen Fang, and Yu-Jui Yvonne Wan. 2013. “The Role of Retinoic Acid in Hepatic Lipid Homeostasis Defined by Genomic Binding and Transcriptome Profiling.” BMC Genomics 14 . http://dx.doi.org/10.1186/1471-2164-14-575
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.
Except where otherwise noted, this item's license is described as: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Related items
Showing items related by title, author, creator and subject.
-
Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
Staudinger, Jeffrey Leonard; Woody, Sarah K.; Sun, Mengxi; Cui, Wenqi (Taylor & Francis, 2013-02)Adverse drug events (ADEs) are a common cause of patient morbidity and mortality and are classically thought to result, in part, from variation in expression and activity of hepatic enzymes of drug metabolism. It is now ... -
Molecular Mechanism of Polybrominated Diphenyl Ether Disposition in the Liver
Pacyniak, Erik Kristofer (University of Kansas, 2010-10-01)Polybrominated diphenyl ethers (PBDEs) were introduced in the late 1970's as additive flame retardants incorporated into textiles, electronics, plastics and furniture. Although 2,2',3,3',4,4',5,5',6,6'-decabromodiphenyl ... -
Cannabinoid 2 Receptor- and Beta Arrestin 2-Dependent Upregulation of Serotonin 2A Receptors
Franklin, Jade M.; Vasiljevik, Tamara; Prisinzano, Thomas E.; Carrasco, Gonzalo A. (Elsevier, 2012-07-28)Recent evidence suggests that cannabinoid receptor agonists may regulate serotonin 2A (5-HT2A) receptor neurotransmission in the brain, although no molecular mechanism has been identified. Here, we present experimental ...